{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T07:22:20Z","timestamp":1770708140944,"version":"3.49.0"},"reference-count":30,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA12473"],"award-info":[{"award-number":["CA12473"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA174777"],"award-info":[{"award-number":["CA174777"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Institute for Prostate and Urologic Cancer, Minneamrita Therapeutics, LLC"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostate"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1002\/pros.23298","type":"journal-article","created":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T09:51:36Z","timestamp":1485942696000},"page":"584-596","source":"Crossref","is-referenced-by-count":25,"title":["Minnelide Inhibits Androgen Dependent, Castration Resistant Prostate Cancer Growth by Decreasing Expression of Androgen Receptor Full Length and Splice Variants"],"prefix":"10.1002","volume":"77","author":[{"given":"Sumit","family":"Isharwal","sequence":"first","affiliation":[{"name":"Department of Urology; Institute for Prostate and Urologic Cancers; University of Minnesota; Minneapolis Minnesota"},{"name":"Department of Surgery; University of Minnesota; Minneapolis Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shrey","family":"Modi","sequence":"additional","affiliation":[{"name":"Department of Surgery; University of Minnesota; Minneapolis Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nivedita","family":"Arora","sequence":"additional","affiliation":[{"name":"Department of Surgery; University of Minnesota; Minneapolis Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Charles","family":"Uhlrich","sequence":"additional","affiliation":[{"name":"Department of Surgery; University of Minnesota; Minneapolis Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhuwan","family":"Giri","sequence":"additional","affiliation":[{"name":"Department of Surgery; University of Minnesota; Minneapolis Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usman","family":"Barlass","sequence":"additional","affiliation":[{"name":"Department of Surgery; University of Minnesota; Minneapolis Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman","family":"Soubra","sequence":"additional","affiliation":[{"name":"Department of Urology; Institute for Prostate and Urologic Cancers; University of Minnesota; Minneapolis Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Chugh","sequence":"additional","affiliation":[{"name":"Department of Surgery; University of Minnesota; Minneapolis Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott M.","family":"Dehm","sequence":"additional","affiliation":[{"name":"Department of Urology; Institute for Prostate and Urologic Cancers; University of Minnesota; Minneapolis Minnesota"},{"name":"Department of Laboratory Medicine and Pathology; University of Minnesota; Minneapolis Minnesota"},{"name":"Masonic Cancer Center; University of Minnesota; Minneapolis Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Dudeja","sequence":"additional","affiliation":[{"name":"Department of Surgery; University of Minnesota; Minneapolis Minnesota"},{"name":"Miller School of Medicine; University of Miami; Miami Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok","family":"Saluja","sequence":"additional","affiliation":[{"name":"Department of Surgery; University of Minnesota; Minneapolis Minnesota"},{"name":"Miller School of Medicine; University of Miami; Miami Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sulagna","family":"Banerjee","sequence":"additional","affiliation":[{"name":"Department of Surgery; University of Minnesota; Minneapolis Minnesota"},{"name":"Miller School of Medicine; University of Miami; Miami Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Badrinath","family":"Konety","sequence":"additional","affiliation":[{"name":"Department of Urology; Institute for Prostate and Urologic Cancers; University of Minnesota; Minneapolis Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,2,1]]},"reference":[{"issue":"1","key":"10.1002\/pros.23298-BIB0001|pros23298-cit-0001","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"10.1002\/pros.23298-BIB0002|pros23298-cit-0002","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.urolonc.2015.01.008","article-title":"Battling resistance mechanisms in antihormonal prostate cancer treatment: Novel agents and combinations","volume":"33","author":"De Maeseneer","year":"2015","journal-title":"Urol Oncol"},{"issue":"3","key":"10.1002\/pros.23298-BIB0003|pros23298-cit-0003","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ctrv.2013.09.011","article-title":"Castration-resistant prostate cancer: Adaptive responses in the androgen axis","volume":"40","author":"Egan","year":"2014","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"10.1002\/pros.23298-BIB0004|pros23298-cit-0004","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ucl.2012.07.003","article-title":"Targeting the androgen receptor","volume":"39","author":"Friedlander","year":"2012","journal-title":"Urol Clin North Am"},{"issue":"2","key":"10.1002\/pros.23298-BIB0005|pros23298-cit-0005","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1209096","article-title":"Abiraterone in metastatic prostate cancer without previous chemotherapy","volume":"368","author":"Ryan","year":"2013","journal-title":"New Eng J Med"},{"issue":"5","key":"10.1002\/pros.23298-BIB0006|pros23298-cit-0006","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJMoa1405095","article-title":"Enzalutamide in metastatic prostate cancer before chemotherapy","volume":"371","author":"Beer","year":"2014","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1002\/pros.23298-BIB0007|pros23298-cit-0007","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.cell.2013.07.029","article-title":"A gain-of-function mutation in DHT synthesis in castration-resistant prostate cancer","volume":"154","author":"Chang","year":"2013","journal-title":"Cell"},{"key":"10.1002\/pros.23298-BIB0008|pros23298-cit-0008","doi-asserted-by":"crossref","first-page":"e00499","DOI":"10.7554\/eLife.00499","article-title":"Overcoming mutation-based resistance to antiandrogens with rational drug design","volume":"2","author":"Balbas","year":"2013","journal-title":"eLife"},{"issue":"2","key":"10.1002\/pros.23298-BIB0009|pros23298-cit-0009","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1158\/0008-5472.CAN-12-3630","article-title":"Androgen receptor splice variants mediate enzalutamide resistance in castration-resistant prostate cancer cell lines","volume":"73","author":"Li","year":"2013","journal-title":"Cancer Res"},{"issue":"11","key":"10.1002\/pros.23298-BIB0010|pros23298-cit-0010","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMoa1315815","article-title":"AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer","volume":"371","author":"Antonarakis","year":"2014","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1002\/pros.23298-BIB0011|pros23298-cit-0011","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1014618","article-title":"Abiraterone and increased survival in metastatic prostate cancer","volume":"364","author":"de Bono","year":"2011","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1002\/pros.23298-BIB0012|pros23298-cit-0012","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJMoa1207506","article-title":"Increased survival with enzalutamide in prostate cancer after chemotherapy","volume":"367","author":"Scher","year":"2012","journal-title":"New Eng J Med"},{"issue":"156","key":"10.1002\/pros.23298-BIB0013|pros23298-cit-0013","doi-asserted-by":"crossref","first-page":"156ra139","DOI":"10.1126\/scitranslmed.3004334","article-title":"A preclinical evaluation of minnelide as a therapeutic agent against pancreatic cancer","volume":"4","author":"Chugh","year":"2012","journal-title":"Sci Transl Med"},{"issue":"19","key":"10.1002\/pros.23298-BIB0014|pros23298-cit-0014","doi-asserted-by":"crossref","first-page":"9407","DOI":"10.1158\/0008-5472.CAN-07-1077","article-title":"Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70","volume":"67","author":"Phillips","year":"2007","journal-title":"Cancer Res"},{"issue":"10","key":"10.1002\/pros.23298-BIB0015|pros23298-cit-0015","doi-asserted-by":"crossref","first-page":"e77411","DOI":"10.1371\/journal.pone.0077411","article-title":"Minnelide: A novel therapeutic that promotes apoptosis in non-small cell lung carcinoma in vivo","volume":"8","author":"Rousalova","year":"2013","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1002\/pros.23298-BIB0016|pros23298-cit-0016","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.surg.2014.04.055","article-title":"Sorafenib and triptolide as combination therapy for hepatocellular carcinoma","volume":"156","author":"Alsaied","year":"2014","journal-title":"Surgery"},{"issue":"2","key":"10.1002\/pros.23298-BIB0017|pros23298-cit-0017","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.canlet.2013.02.050","article-title":"Minnelide reduces tumor burden in preclinical models of osteosarcoma","volume":"335","author":"Banerjee","year":"2013","journal-title":"Cancer Lett"},{"issue":"5","key":"10.1002\/pros.23298-BIB0018|pros23298-cit-0018","doi-asserted-by":"crossref","first-page":"e37693","DOI":"10.1371\/journal.pone.0037693","article-title":"Triptolide inhibits the proliferation of prostate cancer cells and down-regulates SUMO-specific protease 1 expression","volume":"7","author":"Huang","year":"2012","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1002\/pros.23298-BIB0019|pros23298-cit-0019","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.7314\/APJCP.2013.14.10.5663","article-title":"Triptolide inhibits histone methyltransferase EZH2 and modulates the expression of its target genes in prostate cancer cells","volume":"14","author":"Tamgue","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"issue":"9","key":"10.1002\/pros.23298-BIB0020|pros23298-cit-0020","doi-asserted-by":"crossref","first-page":"8763","DOI":"10.1007\/s11033-012-1737-2","article-title":"Triptolide sensitizes TRAIL-induced apoptosis in prostate cancer cells via p53-mediated DR5 up-regulation","volume":"39","author":"Xiaowen","year":"2012","journal-title":"Mol Biol Rep"},{"issue":"47","key":"10.1002\/pros.23298-BIB0021|pros23298-cit-0021","doi-asserted-by":"crossref","first-page":"33927","DOI":"10.1074\/jbc.M113.500983","article-title":"Triptolide-induced cell death in pancreatic cancer is mediated by O-GlcNAc modification of transcription factor Sp1","volume":"288","author":"Banerjee","year":"2013","journal-title":"J Biol Chem"},{"issue":"45","key":"10.1002\/pros.23298-BIB0022|pros23298-cit-0022","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1038\/onc.2011.637","article-title":"AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression","volume":"31","author":"Li","year":"2012","journal-title":"Oncogene"},{"issue":"11","key":"10.1002\/pros.23298-BIB0023|pros23298-cit-0023","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1111\/j.1464-410X.2012.11445.x","article-title":"Targeting the androgen receptor signalling axis in castration-resistant prostate cancer (CRPC)","volume":"110","author":"Tsao","year":"2012","journal-title":"BJU Int"},{"issue":"6","key":"10.1002\/pros.23298-BIB0024|pros23298-cit-0024","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1158\/0008-5472.CAN-08-3795","article-title":"A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth","volume":"69","author":"Guo","year":"2009","journal-title":"Cancer Res"},{"issue":"15","key":"10.1002\/pros.23298-BIB0025|pros23298-cit-0025","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1158\/1078-0432.CCR-08-0531","article-title":"Delineation of TMPRSS2-ERG splice variants in prostate cancer","volume":"14","author":"Hu","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1002\/pros.23298-BIB0026|pros23298-cit-0026","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12672-014-0171-4","article-title":"Identification of androgen receptor splice variant transcripts in breast cancer cell lines and human tissues","volume":"5","author":"Hu","year":"2014","journal-title":"Horm Cancer"},{"issue":"10","key":"10.1002\/pros.23298-BIB0027|pros23298-cit-0027","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1158\/1535-7163.MCT-09-0549","article-title":"Triptolide is an inhibitor of RNA polymerase I and II-dependent transcription leading predominantly to down-regulation of short-lived mRNA","volume":"8","author":"Vispe","year":"2009","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"10.1002\/pros.23298-BIB0028|pros23298-cit-0028","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nchembio.522","article-title":"XPB, a subunit of TFIIH, is a target of the natural product triptolide","volume":"7","author":"Titov","year":"2011","journal-title":"Nat Chemical Biol"},{"issue":"1","key":"10.1002\/pros.23298-BIB0029|pros23298-cit-0029","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/jcb.23359","article-title":"KLF6\/Sp1 initiates transcription of the tmsg-1 gene in human prostate carcinoma cells: An exon involved mechanism","volume":"113","author":"Gong","year":"2012","journal-title":"J Cell Biochem"},{"issue":"4","key":"10.1002\/pros.23298-BIB0030|pros23298-cit-0030","doi-asserted-by":"crossref","first-page":"e35130","DOI":"10.1371\/journal.pone.0035130","article-title":"Modulation of the activity of Sp transcription factors by mithramycin analogues as a new strategy for treatment of metastatic prostate cancer","volume":"7","author":"Malek","year":"2012","journal-title":"PLoS ONE"}],"container-title":["The Prostate"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpros.23298","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pros.23298","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T05:02:24Z","timestamp":1625461344000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pros.23298"}},"subtitle":["Minnelide Inhibits CRPC by Decreasing AR Splice Variants"],"short-title":[],"issued":{"date-parts":[[2017,2,1]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,5]]}},"URL":"https:\/\/doi.org\/10.1002\/pros.23298","archive":["Portico"],"relation":{},"ISSN":["0270-4137"],"issn-type":[{"value":"0270-4137","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2,1]]}}}